Search Results 1671-1680 of 18453 for Immunode

1. Publications - Eunhee S. Yi, M.D. - Mayo Clinic

   GLILD Revisited: Pulmonary Pathology of Common Variable and Selective IgA Immunodeficiency. Am J Surg Pathol. 2020 Aug; 44 (8):1073-1081. View PubMed; Woge MJ ...

2. Darunavir and cobicistat (oral route) - Side effects & dosage - Mayo Clinic

   Darunavir and cobicistat combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is the virus that ...

3. Study to Evaluate the Safety and Efficacy of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Previously Untreated Adults With TP53 Mutant Acute Myeloid Leukemia - Mayo Clinic

   Known active or chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection or human immunodeficiency virus (HIV) infection in medical history.

4. Testing The Use Of The Combination Of Selumetinib And Olaparib Or Selumetinib Alone Targeted Treatment For RAS Pathway Mutant Recurrent Or Persistent Ovarian And Endometrial Cancers, A ComboMATCH Treatment Trial - Mayo Clinic

   - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of registration are ...

5. Delavirdine (oral route) - Side effects & dosage - Mayo Clinic

   Description. Delavirdine is used, in combination with other medicines, in the treatment of the infection caused by the human immunodeficiency virus (HIV).

6. A Study to Assess the Effectiveness and Safety of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis - Mayo Clinic

   ... . Known or suspected immunodeficiency disorder, including history of invasive opportunistic infections (e.g., TB, histoplasmosis, listeriosis ...

7. Study Of Targeted Therapy Vs. Chemotherapy In Patients With Thyroid Cancer - Mayo Clinic

   * Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization ...

8. Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for Locally Advanced or Metastatic ER+/HER2− Breast Cancer - Mayo Clinic

   History of a positive human immunodeficiency virus (HIV) or hepatitis B virus (HBV) test. Screening is not required for enrollment. Hepatitis C virus (HCV) ...

9. NVD003 Compared with Iliac Crest Bone Graft in Pediatric Participants Treated Surgically for Congenital Pseudarthrosis of the Tibia - Mayo Clinic

   Participant has serology and molecular test results at Visits 1 and 2 excluding the presence of human T-cell lymphoma virus, human immunodeficiency virus, ...

10. Temsirolimus and Bevacizumab in Treating Patients with Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer - Mayo Clinic

    Known human immunodeficiency virus (HIV)-positive; ENDOMETRIAL CANCER (PERAMANENTLY CLOSED TO ENROLLMENT). Received prior radiotherapy to any portion of the ...